Gut microbiome study challenges established cancer biomarkers, identifies new bacterial links to colorectal cancer

FHS
May 2, 2024
2:51 am

Study identified that several specific bacterial species were significantly associated with colorectal cancer, challenging previous assumptions about established biomarkers once adjusted for important covariates.

NUC-7738 by NuCana for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 27, 2023

Lobe Sciences Announces Update | Psychedelic Invest

VANCOUVER, British Columbia, June 04, 2024–(BUSINESS WIRE)–Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a biopharmaceutical company focused on developing transformative medicines

June 11, 2024

New biosensor technology could revolutionize mpox diagnosis

A new variant of human mpox has claimed the lives of approximately 5% of people with reported infections in the Democratic Republic of the Congo

November 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.